Cart
sales@molnova.com
Proinsulin C-peptide human
CAS No. 33017-11-7
Proinsulin C-peptide human ( )
Catalog No. M30350 CAS No. 33017-11-7
Proinsulin C-peptide (human) is a 31-amino acid peptide that connects the Proinsulin a and B chains, ensuring its proper folding, biological activity, and regulation of cellular functions.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 100MG | Get Quote | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
Biological Information
-
Product NameProinsulin C-peptide human
-
NoteResearch use only, not for human use.
-
Brief DescriptionProinsulin C-peptide (human) is a 31-amino acid peptide that connects the Proinsulin a and B chains, ensuring its proper folding, biological activity, and regulation of cellular functions.
-
DescriptionProinsulin C-peptide (human) is a 31-amino acid peptide that connects the Proinsulin a and B chains, ensuring its proper folding, biological activity, and regulation of cellular functions.
-
Synonyms
-
PathwayOthers
-
TargetOther Targets
-
Recptor——
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number33017-11-7
-
Formula Weight3020.3
-
Molecular FormulaC129H211N35O48
-
Purity>98% (HPLC)
-
Solubility——
-
SMILES——
-
Chemical Name
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
R. S. Mughal, et al. Cellular mechanisms by which proinsulin C-peptide prevents insulin-induced neointima formation in human saphenous vein. Diabetologia. 2010 Aug;53(8):1761-71.
molnova catalog
related products
-
Pomalidomide-C9-COOH
Pomalidomide-C9-COOH is a synthesized E3 ligase ligand-linker conjugate that incorporates the Pomalidomide based CRBN ligand and linker used in PROTAC technology.
-
Etomoxir
An irreversible inhibitor of carnitine palmitoyltransferase-1 (CPT-1) that inhibits fatty acid β-oxidation in rat liver with IC50 of 5-20 nM.
-
(+)-JQ1 PA
(+)-JQ1 PA is a derivative of the Bromodomain and extra-terminal (BET) inhibitor JQ1, with an IC50 of 10.4 nM.
